Novel mechanism of resistance to folate analogues: ribonucleoside diphosphate reductase deficiency in bacteriophage T4.
Some spontaneously occurring bacteriophage T4 mutants (far mutants) were able to form plaques in the presence of concentrations of folate analogues that completely inhibit plaque formation by wild-type phage T4. Some of these far mutants were shown to be ribonucleoside diphosphate (RDP) reductase (EC 1.17.4.1) deficient, and some independently isolated RDP reductase-deficient mutants (nrd mutants) were shown to be folate analogue resistant. The map positions of the RDP reductase-deficient far mutants were shown to be within the genes controlling the phage-induced RDP reductase activity.
D002874:Chromosome Mapping; D003090:Coliphages / Q000187:drug effects / Q000201:enzymology*; D004352:Drug Resistance, Microbial; D005492:Folic Acid / Q000031:analogs & derivatives* / Q000494:pharmacology; D009154:Mutation; D012262:Ribonucleoside Diphosphate Reductase / Q000378:metabolism*; D012264:Ribonucleotide Reductases / Q000378:metabolism*
D005492:Folic Acid; D012264:Ribonucleotide Reductases; D012262:Ribonucleoside Diphosphate Reductase